Prem Premsrirut PhD
Dr. Premsrirut is CEO of Mirimus and an expert in the development and use of RNAi transgenic mice. She was an inventor of technological advancements that lead to the development of a high-throughput platform for rapid and efficient generation of conditional RNAi transgenic mice. She pioneered a novel approach for the generation of “speedy” chimeric GEMMs based on rederivation of mouse embryonic stem cells (ESCs) from existing mouse strains with a predisposition to cancer. Dr. Premsrirut received a Ph.D. in genetics following her training in the laboratory of Dr. Scott Lowe at Cold Spring Harbor Laboratory.